|
Q2 FY2022
As of Jul 31, 2021
|
Q1 FY2022
As of Apr 30, 2021
|
Q4 FY2021
As of Jan 31, 2021
|
Q3 FY2021
As of Oct 31, 2020
|
Q2 FY2021
As of Jul 31, 2020
|
Q1 FY2021
As of Apr 30, 2020
|
Q4 FY2020
As of Jan 31, 2020
|
Q3 FY2020
As of Oct 31, 2019
|
Q2 FY2020
As of Jul 31, 2019
|
Q1 FY2020
As of Apr 30, 2019
|
Q4 FY2019
As of Jan 31, 2019
|
Q3 FY2019
As of Oct 31, 2018
|
Q2 FY2019
As of Jul 31, 2018
|
Q1 FY2019
As of Apr 30, 2018
|
Q4 FY2018
As of Jan 31, 2018
|
Q3 FY2018
As of Oct 31, 2017
|
Q2 FY2018
As of Jul 31, 2017
|
Q1 FY2018
As of Apr 30, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Marketable securities | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Contract assets | ||||||||||||||||||
| Deferred costs | ||||||||||||||||||
| Deferred contract costs | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Marketable securities, non-current | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Deferred costs, non-current | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Deferred contract costs, non-current | ||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued compensation | ||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||
| Contract liabilities | ||||||||||||||||||
| Contract liabilities | ||||||||||||||||||
| Other contract liabilities | ||||||||||||||||||
| Total contract liabilities | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Long-term debt | ||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||
| Contract liabilities, non-current | ||||||||||||||||||
| Contract liabilities | ||||||||||||||||||
| Other contract liabilities | ||||||||||||||||||
| Total contract liabilities, non-current | ||||||||||||||||||
| Other accrued liabilities, non-current | ||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||||||||
| Preferred stock, $0.00005 par value; 20,000,000 shares authorized, no shares issued and outstanding as of July 31, 2021 and January 31, 2021 | ||||||||||||||||||
| Common stock $0.00005 par value; 1,200,000,000 shares authorized as of July 31, 2021 and January 31, 2021; 296,212,583 and 291,220,735 shares issued and outstanding as of July 31, 2021 and January 31, 2021, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| TOTAL STOCKHOLDERS’ EQUITY | ||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||
Loading...